Infectious Disease Diagnostics Market, 2026
Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques.
- Infectious disease IVD products include reagents, consumables, and instruments based primarily on immunoassays, molecular technologies, and conventional microbiology techniques.
- Data provided include the following:
World Infectious Disease Diagnostic Test Market, 2018-2026 ($ millions)
Global Infectious Disease IVD Demand by Product Group 2018 - 2026 (million dollars) (STDs, Hepatitis, HIV/AIDS, HAIs, ID/AST, Influenza, Tuberculosis, TORCH, Other, Total Demand)
Global Sexually Transmitted Disease (STD) IVD Demand by Test Type & Condition 2018 - 2026 (million dollars) (By Type of Test: Immunoassay, Molecular, Other; By Condition: Chlamydia, HPV, Gonorrhea, Herpes HSV-2, Syphilis, Other; Global STD IVD Demand)
Global Hepatitis IVD Demand by Test Type 2018 - 2026 (million dollars) (Laboratory Tests, Blood Screening, POC Tests, Global Hepatitis IVDs)
Global HIV/AIDS IVD Demand by Test Type 2018 - 2026 (million dollars) (Laboratory Tests, Blood Screening, POC Tests, Global HIV/AIDS IVDs)
Global Healthcare-Associated Infections (HAIs) IVD Demand by Test Type & Condition 2018 - 2026 (million dollars) (By Type of Test: Immunoassay, Molecular, Microbiology; By Condition: C. diff, Sepsis, MRSA, VRE, Other HAIs; Global HAIs IVDs)
Identification/Antibiotic Susceptibility Testing (ID/AST) Demand by Test Type 2018 - 2026 (million dollars) (Automated Tests, Manual Tests, Global ID/AST)
Global Influenza Testing IVD Demand by Test Type 2018 - 2026 (million dollars) (Rapid ID Tests, Molecular Tests, Other Tests, Global Influenza IVDs)
Global Tuberculosis (TB) Testing IVD Demand by Test Type 2018 - 2026 (million dollars) (Microbiology Tests, POC Tests, Molecular Tests, Global Tuberculosis IVDs)
Global Other Infectious Disease IVD Demand by Condition 2018 - 2026 (million dollars) (Malaria, Streptococcal Infections, Lyme Disease, Fungal Infections, Parasitic Conditions, RSV, Emerging Infections, Dengue Fever, All Other Conditions, Global Other Infection IVDs)
The report also reviews various infectious disease testing technologies (immunoassay, microbiology, and molecular), markets (hospital and independent testing laboratories, POC and POL laboratories, blood banks, and other end-users), and products (reagents and consumables and instruments):
Global Infectious Disease IVD Reagents, Consumables, & Instruments Demand 2018 - 2026 (million dollars) (Reagents/Consumables: STDs, Hepatitis, HIV/AIDS, HAIs, ID/AST, Influenza, Tuberculosis, TORCH-Related, Other; Instruments & Systems; Global infection IVDs)
Global Infectious Disease IVD Demand by Technology 2018 - 2026 (million dollars) (Immunoassay, Molecular, Microbiology & Related, Global Infection IVDs)
Global Infectious Disease IVD Demand by End-Use Market 2018 - 2026 (million dollars) (Hospitals, Clinical Laboratories, POC Laboratories, Other Markets, Global Infection IVDs)
Based on a high level of national health expenditures and patient activity and the large role played by private medical providers in the healthcare system, the U.S. will remain the largest and most diversified infectious disease testing market. - The report looks at market drivers, including external market influences that are promoting the development and use of improved infectious disease diagnostics.
- The report details the major competitors that are global market leaders in infectious disease testing products and technologies, including an overview and an outline of these company's infectious disease IVD products: